Any feedback?
Literature summary for 1.3.1.24 extracted from
- Biliverdin reductase as a target in drug research and development Facts and hypotheses (2021), Free Radic. Biol. Med., 172, 521-529 .
Application
| Application | Comment | Organism |
|---|---|---|
| diagnostics | peripheral biomarker for the early diagnosis of Alzheimer's disease | Homo sapiens |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | P53004 | - |
- |
Source Tissue
| Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|
| gastric fundus | mucosal epithelial cells and endothelium of intramural vessels | Homo sapiens | - |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| Biliverdin reductase-A | - |
Homo sapiens |
General Information
| General Information | Comment | Organism |
|---|---|---|
| metabolism | the enzyme catalyzes the reduction of heme-derived biliverdin into bilirubin, which is a powerful endogenous free radical scavenger | Homo sapiens |
| physiological function | the enzyme is involved in the pathogenesis of neurodegenerative, metabolic, cardiovascular and immune-inflammatory diseases as well as in cancer | Homo sapiens |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
